Author:
Xiang Xin,Chen Xuejie,He Yue,Wang Yiwei,Xia Weitong,Ye Shuyu,Wang Sidan,Xiao Yi,Li Quansi,Wang Xiaoyan,Luo Weiwei,Li Jingbo
Abstract
BackgroundPancreatic cancer is renowned for its elevated incidence and mortality rates on a global scale. The disease burden of pancreatic cancer is anticipated to increase, particularly in Asia, due to its vast and rapidly aging population.MethodsData from the Global Burden of Disease 2019 were analyzed for pancreatic cancer burden across 52 countries in Asia, including the incidence, mortality, and disability-adjusted life years (DALY) for pancreatic cancer, with a focus on risk factors such as high body mass index (BMI), elevated fasting plasma glucose, and smoking. We applied the Estimated Annual Percentage Change, the Age–Period–Cohort model, and decomposition analysis to evaluate incidence trends and effects.ResultsFrom 1990 to 2019, both incidence and mortality rates of pancreatic cancer in Asia significantly increased, with an average annual standardized incidence rate change of 1.73%. Males consistently exhibited higher rates than females, with smoking as a key risk factor. Central Asia reported the highest rates, and South Asia the lowest. The incidence rose with age, peaking in those aged 70~74. The disease burden increased in all age groups, particularly in populations aged 55 and above, representing 84.41% of total cases in 2019, up from 79.01% in 1990. Pancreatic cancer ranked the fifth in incidence among six major gastrointestinal tumors but presented a significant growth rate of mortality and DALY.ConclusionWith the growing, aging population in Asia, the pancreatic cancer burden is projected to escalate, bringing a significant public health challenge. Hence, comprehensive public health strategies emphasizing early detection, risk modification, and optimized treatment of pancreatic cancer are imperative.
Reference48 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018
2. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma;Grossberg;CA Cancer J Clin,2020
3. Epidemiology of pancreatic cancer: an update;Maisonneuve;Dig Dis,2010
4. Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis;Cai;Cancer Lett,2021
5. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment;Wood;Gastroenterology,2022